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background: In this subanalysis of the HF Assessment with Bnp In The Home (HABIT) trial, we examine the results of the home B-type natriuretic 
peptide (BNP) testing and weight monitoring in 160 patients with HFPEF and HFREF.
Methods: The study was a multi-center, single-arm double-blinded observational prospective clinical trial designed to monitor daily BNP and 
weight changes.
results: HFPEF patients compared to HFREF patients were older, more obese with lower BNP values. BNP dispersion is greater in HFPEF than in 
HFREF due to the rapid fluctuations. A moving average of BNP produces a slowly varying risk measure (fBNP) that disperses similarly between both 
groups and conveys a similar risk for ADHF. In HFPEF, a rapid rise in BNP >200 pg/mL within 3 days is associated with 4 times risk of ADHF, whereas 
the same rapid rise is not significant in HFREF. Weight gain of at least 5 lbs. in 3 days had a high specificity but low sensitivity for ADHF in both 
groups, while a threshold of >2 lbs. weight gain over 3 days in patients with HFPEF (but not HFREF) is a sensitive cutoff for decompensation (60% 
sensitive and 77% specific). 
conclusions: Patients with HFPEF and HFREF have variations in their BNP and weight prior to decompensation. In those with HFPEF, a 3 day period 
characterized by >2 lbs. of weight gain and/or > 200 pg/mL of BNP rise is significantly associated with decompensation. Over the longer time-scale, 
similar fold changes in the moving average of BNP convey similar levels of risk for ADHF in each group.
 
